Cross-Reactivity of Selected Benzofurans with Commercial Amphetamine and Ecstasy Immunoassays in Urine

References

• European Monitoring Centre for Drugs and Drug Addiction and Europol (2016), EU drug markets report: strategic overview, EMCDDA–Europol joint publications, Publications Office of the European Union, Luxembourg.
   Google Scholar
• Vaiano F , BusardòFP, PalumboDet al. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases. J. Pharm. Biomed. Anal. 129, 441–449 (2016).
   PubMed Web of Science ®Google Scholar
• Regester LE , ChmielJD, HollerJMet al. Determination of designer drug cross-reactivity on five commercial immunoassay screening kits. J. Anal. Toxicol. 39, 144–151 (2015).
   PubMed Web of Science ®Google Scholar
• Beck O , RausbergL, Al-SaffarYet al. Detectability of new psychoactive substances, ‘legal highs’, in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. Drug Test Anal. 6, 492–499 (2014).
   PubMed Web of Science ®Google Scholar
• Owens S. Michael , GunnellMellinda, CarrollF. Ivy. US 8, 853, 146 B2 (2008).
   Google Scholar
• Suttijitpaisal P , RatanabanangkoonK. Immunoassays of amphetamines: immunogen structure vs antibody specificity. Asian Pac. J. Allergy Immunol. 10, 159–164 (1992).
   PubMed Web of Science ®Google Scholar
• Kerrigan S , MellonMB, BanuelosS, ArndtC. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines. J. Anal. Toxicol. 35, 444–451 (2011).
   PubMed Web of Science ®Google Scholar
• Moeller KE , KissackJC, AtayeeRS, LeeKC. Clinical Interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin. Proc. 92, 774–796 (2017).
   PubMed Web of Science ®Google Scholar
• King LA . New phenethylamines in Europe. Drug Test Anal. 6, 808–811 (2014).
   PubMed Web of Science ®Google Scholar
• Green SL . Benzofurans and dibenzofurans. In : Novel Psychoactive Substances. DarganPI, WoodDM ( Eds). Academic Press, Elsevier, CA, USA, 283–392 (2013).
   Google Scholar
• Nugteren-van Lonkhuyzen JJ , van RielAJ, BruntTMet al. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug Alcohol Depend. 157, 18–27 (2015).
   PubMed Web of Science ®Google Scholar
• Chan WL , WoodDM, HudsonSet al. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J. Med. Toxicol. 9, 278–281 (2013).
   PubMedGoogle Scholar
• Jebadurai J , SchifanoF, DelucaP. Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (benzofury/6-APB) and NRG-2 with review of available evidence-based literature. Hum. Psychopharmacol. 28, 356–364 (2013).
   PubMed Web of Science ®Google Scholar
• Stanczuk A , MorrisN, GardnerEAet al. Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in internet purchased products. Drug Test Anal. 5, 270–276 (2013).
   PubMed Web of Science ®Google Scholar
• Archer JR , DarganPI, LeeHMet al. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clin. Toxicol. (Phila)52, 160–165 (2014).
   PubMed Web of Science ®Google Scholar
• Elliott S , EvansJ. A 3 year review of new psychoactive substances in casework. Forensic Sci. Int. 243, 55–60 (2014).
   PubMed Web of Science ®Google Scholar
• Strano Rossi S , OdoardiS, GregoriAet al. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Rapid Commun. Mass Spectrom. 28, 1904–1916 (2014).
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . Annual Report 2012: The State of Drugs Problem in Europe. 2017. www.emcdda.europa.eu/attachements.cfm/att_19,0854_EN_TDAC12,001ENC_pdf
   Google Scholar
• Adamowicz P , GierońJ, GilDet al. The prevalence of new psychoactive substances in biological material – a three-year review of casework in Poland. Drug Test Anal. 8, 63–70 (2016).
   PubMed Web of Science ®Google Scholar
• Hondebrink L , Nugteren-van LonkhuyzenJJ, Van Der GouweDet al. Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre. Drug Alcohol Depend. 147, 109–115 (2015).
   PubMed Web of Science ®Google Scholar
• Odoardi S , RomoloFS, Strano-RossiS. A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013–2015. Forensic Sci. Int. 265, 116–120 (2016).
   PubMed Web of Science ®Google Scholar
• Sendino R , ÁlvarezE, Brimeet al. Informe 2016. Alcohol, tabaco y drogas ilegales en España. Observatorio Español de la Droga y las Toxicomanías. Delegación del Gobierno para el Plan Nacional sobre Drogas (2016).
   Google Scholar
• Liu C , JiaW, QianZet al. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe. Drug Test Anal. 9, 199–207 (2017).
   PubMed Web of Science ®Google Scholar
• Iversen L , GibbonsS, TrebleRet al. Neurochemical profiles of some novel psychoactive substances. Eur. J. Pharmacol. 700, 147–151 (2013).
   PubMed Web of Science ®Google Scholar
• Rickli A , KopfS, HoenerMCet al. Pharmacological profile of novel psychoactive benzofurans. Br. J. Pharmacol. 172, 3412–3425 (2015).
   PubMed Web of Science ®Google Scholar
• Advisory Council on the Misuse of Drugs (ACMD) . Benzofurans: A Review of the Evidence of Use and Harm (2013). www.gov.uk/government/uploads/system/uploads/attachment_data/file/26,1783/Benzofuran_compounds_report.pdf
   Google Scholar
• Advisory Council on the Misuse of Drugs (ACMD) . 6-APB and 5-APB: A Review of the Evidence of Use and Harm (2013). www.gov.uk/government/uploads/system/uploads/attachment_data/file/20,4808/J_TCDO_report_on_5-APB_and_NBOMe_compounds.pdf
   Google Scholar
• Jebadurai J , SchifanoF, DelucaP. Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (benzofury/6-APB) and NRG-2 with review of available evidence-based literature. Hum. Psychopharmacol. 28, 356–364 (2013).
   PubMed Web of Science ®Google Scholar
• Chan WL , WoodDM, HudsonSet al. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J. Med. Toxicol. 9, 278–281 (2013).
   PubMedGoogle Scholar
• Erowid Experience Vaults. 6-APB. Jul 2017. www.erowid.org/experiences/subs/exp_6APB.shtml
   Google Scholar
• Erowid Experience Vaults. 5-APB. Jul 2017. www.erowid.org/experiences/subs/exp_5APB.shtml
   Google Scholar
• Reagan-Shaw S , NihalM, AhmadN. Dose translation from animal to human studies revisited. FASEB J. 22, 659–661 (2008).
   PubMed Web of Science ®Google Scholar
• Welter J , KavanaghP, MeyerMRet al. Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques. Anal. Bioanal. Chem. 407, 1371–1388 (2015).
   PubMed Web of Science ®Google Scholar
• Barcelo B , GomilaI. Pharmacology and literature review based on related death and non-fatal case reports of the benzofurans and benzodifurans designer drugs. Curr. Pharm. Des. doi: 10.2174/1381612823666170714155140 (2017) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Vallersnes OM , PersettPS, ØiestadELet al. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Clin. Toxicol. (Phila.)13, 1–9 (2017).
   Google Scholar
• Wille SMR , RichevalC, Nachon-PhanithavongMet al. Prevalence of New Psychoactive Substances and Prescription Drugs in the Belgian Driving under the Influence of Drugs Population. Drug Test Anal. doi: 10.1002/dta.2232 (2017) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Barcelo B , GomilaI, RotoloMCet al. Intoxication caused by new psychostimulants: analytical strategies to disclose acute and chronic use of benzofurans and ethylphenidate. Int. J. Legal Med. doi: 10.1007/s00,414–017–1648–9 (2017) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Hofer KE , FaberK, MüllerDMet al. Acute toxicity associated with the recreational use of the novel psychoactive benzofuran N-methyl-5-(2 aminopropyl) benzofuran. Ann. Emerg. Med. 69, 79–82 (2017).
   PubMed Web of Science ®Google Scholar
• McIntyre IM , GaryRD, TrochtaAet al. Acute 5-(2-aminopropyl)benzofuran (5-APB) intoxication and fatality: a case report with postmortem concentrations. J. Anal. Toxicol. 39, 156–159 (2015).
   PubMed Web of Science ®Google Scholar
• Locatelli CA , LonatiD, BuscagliaEet al. “Benzofury” poisoning that mimics meningoecephalitis/septicemia. Abstracts XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 28–31 May 2013, Copenhagen. Denmark. Clin. Toxicol. 51, 286 (2013).
   Web of Science ®Google Scholar
• Adamowicz P , ZubaD, ByrskaB. Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Forensic Sci. Int. 245, 126–132 (2014).
   PubMed Web of Science ®Google Scholar
• Birch MA , CouchmanL, PietromartireS, KarnaTet al. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride. J. Anal. Toxicol. 37, 233–236 (2013).
   PubMed Web of Science ®Google Scholar
• Quesada L , GomilaI, FeAet al. Fenofibric acid can cause false-positive urine methylenedioxymethamphetamine immunoassay results. J. Anal. Toxicol. 39, 734–740 (2015).
   PubMed Web of Science ®Google Scholar
• Kerrigan S , MellonMB, BanuelosS, ArndtC. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines. J. Anal. Toxicol. 35, 444–451 (2011).
   PubMed Web of Science ®Google Scholar
• Krasowski MD , SiamMG, IyerM, EkinsS. Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays. Ther. Drug Monit. 31, 337–344 (2009).
   PubMed Web of Science ®Google Scholar
• Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), BP (2001). www.fda.gov/downloads/Drugs/Guidance/ucm07,0107.pdf
   Google Scholar
• Kosten T , OwensSM. Immunotherapy for the treatment of drug abuse. Pharmacol. Ther. 108, 76–85 (2005).
   PubMed Web of Science ®Google Scholar
• Peterson EC , GunnellM, CheYet al. Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse. J. Pharmacol. Exp. Ther. 322, 30–39 (2007).
   PubMed Web of Science ®Google Scholar
• Turner GJ , ColbertDL, ChowdryBZ. A broad spectrum immunoassay using fluorescence polarization for the detection of amphetamines in urine. Ann. Clin. Biochem. 28, 588–594 (1991).
   PubMed Web of Science ®Google Scholar
• Budd RD . Amphetamine EMIT-structure versus reactivity. Clin. Toxicol. 18, 91–110 (1981).
   PubMed Web of Science ®Google Scholar
• Budd RD . Amphetamine radioimmunoassay-structure versus reactivity. Clin. Toxicol. 18, 299–316 (1981).
   PubMed Web of Science ®Google Scholar